NCT05920200 Factors Influencing the Results of Treatment in Patients With Hernias of Various Localizations
| NCT ID | NCT05920200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Immanuel Kant Baltic Federal University |
| Condition | Inguinal Hernia |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2020-01-09 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2020-01-09 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study attempts to quantify the relative risks for acute postoperative pain, complications rate, chronic postoperative pain (CPIP) and recurrence rate after different methods of repair of groin, umbilical and incisional hernia depending on surgical technique, mesh type and fixation suture material. For this purpose the investigators will analyze data from the Kalinigrad Hernia Registry (KHR).
Eligibility Criteria
Inclusion Criteria: * All mesh and non-mesh repairs that have been registered in the KHR from January 9, 2020, until December 31, 2023. Exclusion Criteria: * Patients not having a 11-digit state-assigned Personal insurance policy number. * Parastomal hernia; * infected hernias;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05920200 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05920200 currently recruiting?
Yes, NCT05920200 is actively recruiting participants. Contact the research team at Vkakotkin@kantiana.ru for enrollment information.
Where is the NCT05920200 trial being conducted?
This trial is being conducted at Kaliningrad, Russia.
Who is sponsoring the NCT05920200 clinical trial?
NCT05920200 is sponsored by Immanuel Kant Baltic Federal University. The trial plans to enroll 4,000 participants.